Technologies

Vitamin D binding protein as a biomarker for autism enables early detection and treatment

Technology description

Application area

• Biomarker for the early detection and prevention of autism and for predicting future development of autism.
• Diagnostic test for neonatal screening of ASDs.
• Diagnostic test to determine if a future patient or his or her pregnant mother would benefit from vitamin D supplements.
• Treatment that decreases or inhibits Gc globulin such that free Vitamin D levels are increased

Advantages

• Biomarker allows for an early and easy way to screen for ASD.
• Early diagnosis after birth allows for early intervention and the best opportunity to control or avert disease progression.
• Currently, no biomarkers are available to detect ASDs at birth.